Cytokinetics sec filings
WebApr 11, 2024 · Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as … WebMar 13, 2024 · Thornburg Investment Management Inc. acquired a new stake in shares of Cytokinetics, Incorporated (NASDAQ:CYTK - Get Rating) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 74,198 shares of the biop
Cytokinetics sec filings
Did you know?
WebApr 4, 2024 · Pinnacle Associates Ltd. owned approximately 0.30% of Cytokinetics worth $11,556,000 as of its most recent SEC filing. Want Diversified Upside in Biotechnology? … WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining.
WebItem 1.01 Entry into a Material Definitive Agreement. On February 1, 2024, Cytokinetics, Incorporated ("Cytokinetics") entered into a Royalty Purchase Agreement (the "Royalty Agreement") with RPI Finance Trust ("RPI"), an entity related to Royalty Pharma. WebMar 15, 2024 · Wed., March 15, 2024 MarketBeat Advisory Research Inc. lowered its holdings in Cytokinetics, Incorporated ( NASDAQ:CYTK - Get Rating) by 32.7% during the third quarter, according to its most recent filing with the …
WebMar 31, 2024 · CYTK Cytokinetics, Incorporated SEC Filings 8.71K followers $35.19 0.98 ( +2.86%) 4:00 PM 03/31/23 NASDAQ $USD Post-Market: $35.70 +0.51 (+1.45%) 5:56 … WebApr 8, 2024 · Cytokinetics Inc (CYTK) SEC Filing DEF 14A Proxy Statement Report for the fiscal year ending Tuesday, May 10, 2024. Home. SEC Filings. ... Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats. Last10K.com Member Feature. Export Annual and Quarterly Reports to Adobe Acrobat (PDF), Microsoft Word (DOCX), …
WebFeb 24, 2024 · Cytokinetics Inc CIK: 1061983 Ticker: CYTK GET DIRECTION ON YOUR INVESTMENTS Integrate SEC filing data within your own apps using our API Sign up Key Features Various SEC filing data available including balance sheets, cash flows and more Central Index Key (CIK) and ticker conversions for looking up companies
WebPipeline - Cytokinetics A pipeline powered by passion pipeline Research Pre-Clinical Phase 1 Phase 2 Phase 3 CARDIAC MUSCLE Omecamtiv Mecarbil (Heart Failure) Aficamten (oHCM) Aficamten (nHCM) CK-136 (Heart Failure, other) CK-586 SKELETAL MUSCLE Reldesemtiv (ALS) Additional Skeletal Muscle Activators Other Muscle Biology … cytson hermosilloWebNov 4, 2024 · SEC Filings Cytokinetics Inc (CYTK) 10-Q Quarterly Report Fri Nov 04 2024 SEC Filings CYTK Valuations Intrinsic Value Financial Stability Financial Ratios Insider … cytson hermosillo telefonoWebMar 31, 2024 · Latest SEC filings for Cytokinetics, Incorporated (CYTK). Latest SEC filings for Cytokinetics, Incorporated (CYTK) Seeking Alpha Seeking Alpha - Go to … bing fitsWeb11 rows · Apr 5, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and ... cytsonlineWebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 … cyt share priceWebApr 13, 2024 · China Universal Asset Management Co. Ltd. trimmed its holdings in Cytokinetics, Incorporated (NASDAQ:CYTK – Get Rating) by 96.6% during the 4th … cytsoft psychrometric chartWebFind the latest SEC Filings data for Cytokinetics, Incorporated Common Stock (CYTK) at Nasdaq.com. Cytokinetics, Incorporated Common Stock (CYTK) SEC Filings … bing fix